Eye pain and pressure. When the eye pressure rises especially rapidly and exceeds 40 mmHg, pain is felt in the eye. In the case of acute glaucoma crisis, this pain is accompanied by blurred vision and redness of the eye. The glaucoma patient typically experiences a wide range of pain sensations.
Treatment
A local anesthetic is required, such as local anesthetic ophthalmic solutions. An ophthalmic solution must be applied to the entire eye by means of a disposable disposable lancet. It can be administered using a single-use syringe or pipette, or used in an assisted setting using a continuous drip, continuous flow, or continuous pump (Vollmer, 1978).
The intraocular pressure (iOps) must be maintained between 30-40 mmHg. The ophthalmic solution must be applied in the periorbital region, because this is where the optic nerve originates (Pieroni et al., 1976).
The ophthalmic solution must be maintained below 30 mmHg, and as low as possible. The ophthalmic solution may be applied to the entire eye by means of a disposable disposable lancet (Safarine, 1975). If the patient is older than 65 years old, ophthalmic solutions should be prepared for emergency use in the elderly patient.
For younger children, the eye can be irrigated with local anesthetic ophthalmic solution. A syringe or pipette should be used to apply the solution, since it will be administered under the tongue, where the optic nerves originate. In such case, ophthalmic solution must be placed into the patient’s ear and administered by way of a syringe (Safarine, 1975).
When a patient is under general anesthesia, a solution is often sufficient to prevent permanent damage to the optic nerve. It is essential that the ophthalmic solution be kept below 30 mmHg to allow the nerve fibers to survive for at least a few minutes (Safarine, 1975).
The ophthalmic solution must be applied in the periorbital region, because this is where the optic nerve originates (Pieroni et al., 1976).
The treatment of a glaucoma patient is different from other ophthalmic emergencies. A few patients may need intravenous administration of a locally active dilated-endopeptidase solution.
A dilated-endopeptidase solution should be applied to the entire eye and an ophthalmic solution should be administered in the periorbital region (Pieroni et al., 1976).
The solution must be maintained under 30 mmHg to prevent permanent damage to the optic nerve. It is essential that the ophthalmic solution be kept below 30 mmHg to allow the nerve fibers to survive for at least a few minutes (Safarine, 1975).
Acute Cases of Glaucoma
An intravenous ophthalmic solution is usually not needed in the cases of acute glaucoma. The solution must be kept below 30 mmHg to prevent permanent damage to the optic nerve. The solution must be placed into the periorbital region because this is where the optic nerve originates (Pieroni et al., 1976).
The application of an ophthalmic solution to the glaucoma patient must be undertaken only as part of an emergency protocol and in consultation with the ophthalmic consultant.
He is the only one who should be consulted for the application of an ophthalmic solution because he has direct knowledge of the optic nerves of the retina and optic nerves of the choroid. However, he may only give this medication to the eye.
The application of an ophthalmic solution should be performed under a trained emergency surgeon with whom the ophthalmic consultant is familiar. The eye must be removed immediately after the application of the ophthalmic solution and immediately after the ophthalmic surgeon’s injection.
Because of the risk of infection with a dilated-endopeptidase solution, it is essential that a physician be present during the surgical procedure (Safarine, 1975).
The patient should be instructed to wear his or her medical eyewear during the emergency treatment and to have his or her eyes inspected after this.
The medical equipment is designed for surgery and may be uncomfortable for the patient. If the eye is damaged, the ophthalmic surgeon may use a local anesthetic ophthalmic solution to prevent permanent damage (Pieroni et al., 1976).
An ophthalmic solution should be given in a small quantity as a bolus, in the same way as the injection of an opiate to an opiate-dependent patient. This should be done in an ambulatory patient with good vision and without any previous trauma or medical emergency (Vollmer, 1978).
When a patient presents with glaucoma, a local anesthetic is often used. In the first few minutes, however, glaucoma patients sometimes develop hyperpigmentation, because they show increased intraocular pressure.
Glaucoma also causes the appearance of a dark patch behind the retina. The black patch may have been caused by an increased intraocular pressure, which causes a contraction of the optic nerve. Thus, it is important that the ophthalmic solution be applied under the tongue or in a place where the optic nerves originate (Pieroni et al., 1976).
